Am J Transplant, Volume 16, Suppl 3 Archives - Page 121 of 180 - ATC Abstracts

2016 American Transplant Congress
Donor Specific Antibody Used to Predict Crossmatch Results: A Clinically Useful Algorithm Derived from the College of American Pathologists Survey.
S. Wrenn,¹ D.-S. Hain,² S. Harm,² S. Hillyard,² D. Shah,² P. Hammond,² C. Marroquin,¹ M. Fung.²
¹Transplant Surgery, University of Vermont Medical Center, Burlington, VT; ²Pathology, University of Vermont Medical Center, Burlington, VT.
Purpose: While there are multiple modalities to perform a preoperative crossmatch for organ transplant surgery, the cytotoxic crossmatch remains the gold standard for detection of…
2016 American Transplant Congress
Review of Organ Utilization from Increased Infectious Risk Donors.
A. L'Huillier,¹ A. Humar,² C. Payne,³ D. Kumar.²
¹Division of Infectious Diseases, Hospital for Sick Children and University of Toronto, Toronto, Canada; ²Transplant Infectious Diseases and Multi-Organ Transplant Program, University Health Network, Toronto, Canada; ³Trillium Gift of Life Network, Toronto, Canada.
IntroductionDonors with an increased risk of transmitting HIV, HBV or HCV (IRDs) are a potential source of organs. There is a lack of data on…
2016 American Transplant Congress
High Tacrolimus Dose Requirements at Month 6 Are Associated with Inferior Graft Function in Renal Transplant Patients.
O. Rissling, S. Brakemeier, L. Lehner, F. Halleck, O. Staeck, D. Schmidt, K. Budde.
Department of Nephrology, Charité Universitaetsmedizin, Berlin, Germany.
Introduction: Tacrolimus (Tac), the mainstay of immunosuppression in renal transplant (tx) patients (pts) is known for drug induced nephrotoxicity, which may limit graft survival.Methods: In…
2016 American Transplant Congress
Renal Dysfunction at 12 Months Is Not Associated with Everolimus Exposure in De Novo Renal Transplant Recipients.
F. Shihab,¹ Y. Qazi,² S. Mulgaonkar,³ K. McCague,⁴ D. Patel,⁴ V. Peddi,⁵ D. Shaffer.⁶
¹University of Utah, Salt Lake City, UT; ²University of Southern California, Los Angeles, CA; ³Barnabas Health, West Orange, NJ; ⁴Novartis Pharmaceuticals Corporation, East Hanover, NJ; ⁵California Pacific Medical Center, San Francisco, CA; ⁶Vanderbilt University, Nashville, TN.
Renal dysfunction at 1 year post-transplantation is associated with poor graft outcome. Here, we assess post-transplant renal function associated with everolimus (EVR) and tacrolimus (TAC)…
2016 American Transplant Congress
Morbidity and Mortality of Early Post-Operative Acute Kidney Injury in Cardiothoracic Transplant Recipients.
J. Casale, A. Logan, C. Doligalski.
Tampa General Hospital, Tampa, FL.
Purpose: Early acute kidney injury (AKI) in cardiothoracic transplant recipients (CTTR) has not been well described; renal injury defined by the RIFLE criteria has been…
2016 American Transplant Congress
Medicaid Insurance Is Associated with Shorter Time to Transplant Listing After LVAD Implantation.
W. Schultz, M. Yin, Y.-A. Ko, J. Vega, A. Morris.
Emory University School of Medicine, Atlanta, GA.
Introduction: Left-ventricular assist devices (LVAD) and total artificial hearts (TAH) are being increasingly utilized as a bridge to heart transplant (HT). Prior studies have demonstrated…
2016 American Transplant Congress
Acute Rejections and Incidence of De Novo DSA Depend on Donor Factors and Deceased Donor Kidney Associated Risk Assessed by the Kidney Donor Profile Index (KDPI).
O. Staeck, D. Khadzhynov, L. Lehner, A. Kleinsteuber, M. Duerr, E. Schrezenmeier, K. Budde, F. Halleck.
Nephrology, Charite, Berlin, Germany.
Introduction: Little data exist analyzing the influence of donor kidney quality on the immunologic outcome and applying the KDPI in a European cohort.Methods: This retrospective…
2016 American Transplant Congress
Outcomes of Sequential and En Bloc Transplants in the Elderly: 10 Year Review of UNOS Data.
V. Whittaker,¹ R. Gruessner,¹ A. Vikram,² A. Gruessner.
¹Surgery, SUNY Upstate Medical University, Syracuse, NY; ²Medicine, SUNY Upstate Medical University, Syracuse, NY.
To evaluate the outcome of sequential and en bloc transplants in the elderly.Method: Retrospective review UNOS data 2004-2014 kidney transplant alone patients >65 years. Patient…
2016 American Transplant Congress
Soluble ST2 and Cardiovascular (CV) Outcomes and Mortality in Kidney Transplant Candidates.
M. Keddis,¹ Z. El-Zoghby,² A. Gray,² J. Meeusen,² L. Donato,² F. Cosio,² D. Steidley.¹
¹Mayo Clinic, Phoenix, AZ; ²Mayo Clinic, Rochester, MN.
Introduction: Soluble ST2(sST2), involved in T-cell mediated inflammation and cardiac fibrosis, is a better predictor of cardiovascular events(CVE) in heart failure(HF) and is less affected…
2016 American Transplant Congress
Impact of Left Ventricular Diastolic Dysfunction on Patients Being Evaluated for Liver Transplantation.
K. Forde,¹ R. McLean,¹ W. O'Donnell,¹ K. Krok,² M. Patel,¹ G. Lin,³ J. Oh,³ M. Krowka,³ M. Fallon,⁴ S. Kawut.¹
¹Medicine, University of Pennsylvania, Philadelphia, PA; ²Medicine, Penn State Hershey, Hershey, PA; ³Medicine, Mayo Clinic, Rochester, MN; ⁴Medicine, University of Texas Medical School – Houston, Houston, TX.
IntroductionDiastolic dysfunction (DD) is the cardinal finding in cirrhotic cardiomyopathy, a condition in patients with liver disease that is associated with an increased risk of…